Copyright
©2005 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2005; 11(2): 260-263
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.260
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.260
Table 3 Prognostic variables for survival analysis.
| Variable | Mortality (n = 8) | Log-rank test |
| Age (yr) | 0.085 | |
| ≤50 yr | 1/9 | |
| >50 yr | 7/14 | |
| Sex | ||
| Male | 4/11 | 0.95 |
| Female | 4/12 | |
| Location | 0.872 | |
| Gastroduodenal | 5/14 | |
| Intestinal | 3/9 | |
| Surgical margin | 0.047 | |
| Negative | 2/12 | |
| Positive | 6/11 | |
| STI-571 | 0.045 | |
| Yes | 1/9 |
- Citation: Chen TW, Liu HD, Shyu RY, Yu JC, Shih ML, Chang TM, Hsieh CB. Giant malignant gastrointestinal stromal tumors: Recurrence and effects of treatment with STI-571. World J Gastroenterol 2005; 11(2): 260-263
- URL: https://www.wjgnet.com/1007-9327/full/v11/i2/260.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i2.260